Clearline Capital’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Clearline Capital’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-115,463	Closed	-$4.87M	–	145
2023 Q2	$4.87M	Sell	115,463 -145,233	-56%	-$5.87M	0.28%	46
2023 Q1	$9.29M	Buy	260,696 +211,044	+425%	+$7.66M	1.4%	23
2022 Q4	$1.82M	Buy	+49,652	New	+$1.96M	0.33%	69
2019 Q1	–	Sell	-28,451	Closed	-$1.12M	–	59
2018 Q4	$1.12M	Sell	28,451 -117,528	-81%	-$5.46M	0.77%	40
2018 Q3	$7.53M	Buy	145,979 +40,279	+38%	+$1.97M	4.45%	5
2018 Q2	$4.96M	Sell	105,700 -243,979	-70%	-$10.1M	3.22%	9
2018 Q1	$12.4M	Buy	349,679 +24,449	+8%	+$958K	11.48%	1
2017 Q4	$14.2M	Buy	325,230 +162,722	+100%	+$7.6M	7.33%	3
2017 Q3	$8.5M	Buy	162,508 +29,439	+22%	+$1.64M	6.19%	5
2017 Q2	$7.79M	Buy	+133,069	New	+$6.91M	4.91%	8

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Clearline Capital's SYNH Position: Q3 2023 in Review

Clearline Capital sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 115,463 shares — an estimated $4.87M sold.

Clearline Capital first reported a position in SYNH in Q2 2017 and held it in 10 quarters. The position peaked at $14.2M in Q4 2017. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

Clearline Capital reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Clearline Capital sold 115,463 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $4.87M.
Clearline Capital first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2017 and held it in 10 quarters.
Clearline Capital's Syneos Health, Inc. Class A Common Stock position peaked at $14.2M in Q4 2017.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Clearline Capital's 13F filing for Q3 2023, filed 14 Nov 2023.